Mean cost of bringing new drug to US market Is $879.3 million
Jul 02, 2024
R&D has remained relatively stable among large pharma companies despite a 27.3% growth in sales.
Emergence of psychosis in Alzheimer’s disease linked to elevations in p-tau181
Jul 01, 2024
An increase in plasma p-tau181 levels was seen in patients with incident psychosis over follow-up versus those with psychosis at baseline.
Low incidence of delayed intracranial hemorrhage seen in seniors after head injury
Jul 03, 2024
No differences were seen in rates of delayed intracranial hemorrhage between those who have been versus those who have not been prescribed anticoagulants.
American Diabetes Association, June 21-24
Jul 01, 2024
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians,...
Racial differences seen in financial hardship among older cancer survivors
Jul 01, 2024
Income and area-level disadvantage are the largest contributors to racial differences.
Patient–primary care provider language concordance tied to better outcomes
Jul 02, 2024
The findings were seen for non-English and non-French speakers living in Canada.
Fourth dairy worker infected with bird flu, but CDC says public risk still low
Jul 03, 2024
The latest case, in Colorado, follows cases in Texas and Michigan.
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...